Registry study for primary cutaneous T-cell lymphoma
Part of Cancer, Skin clinical trials.
This study follows people with primary cutaneous T-cell lymphoma who are seen at the Dermatology Unit in Pavia. It collects information to better understand the disease and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with primary cutaneous T-cell lymphoma
- You are receiving care at the Dermatology Unit in Pavia
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to understand how common skin lymphomas are in Italy. You might be able to help if you have been diagnosed with a skin lymphoma.
This study is for adults newly diagnosed with lymphoma in the last 3 months, including those who may have started treatment. It aims to collect information on patients in Italy.
This trial looks at people with lymphoma that involves mainly the heart (and possibly the lining around the heart) and was treated first with chemotherapy plus an anti-CD20 antibody. The goal is to understand outcomes from this specific treatment approach in patients diagnosed over a defined time period.
This study looks at what treatments work for people with primary cutaneous lymphoma, and how patients do over time. It uses real patient information from participating hospitals to understand outcomes after diagnosis.
This study looks at skin lymphomas (a type of white blood cell cancer that starts in the skin) to find factors that predict how the disease will progress and to identify new ways to treat it. By joining, you help researchers understand and improve treatment for this condition.
This study looks at the bacteria (microbiome) living on the skin in people with specific skin conditions, and in healthy volunteers. The results may help researchers understand what skin microbes have to do with these diseases.
Hear when a new Primary Cutaneous T-cell Lymphomas NCT Number trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.